Should You Sell Ginkgo Bioworks Holdings Inc (DNA) Stock Friday Morning?

Friday, August 19, 2022 08:47 AM | InvestorsObserver Analysts

Mentioned in this article

Ginkgo Bioworks Holdings Inc (DNA) has fallen Friday morning, with the stock declining -3.08% in pre-market trading to 3.15. DNA's short-term technical score of 62 indicates that the stock has traded more bullishly over the last month than 62% of stocks on the market. In the Biotechnology industry, which ranks 119 out of 146 industries, DNA ranks higher than 71% of stocks. Ginkgo Bioworks Holdings Inc has risen 0.93% over the past month, closing at $2.92 on July 22. During this period of time, the stock fell as low as $2.61 and as high as $4.91. DNA has an average analyst recommendation of Strong Buy. The company has an average price target of $8.26.

DNA has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on DNA!
Ginkgo Bioworks Holdings Inc has a Long-Term Technical rank of 47. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 53% of the market scoring higher. In the Biotechnology industry which is number 83 by this metric, DNA ranks better than 83% of stocks.

Important Dates for Investors in DNA:

-Ginkgo Bioworks Holdings Inc is set to release earnings on 11/13/2022. Over the last 12 months, the company has reported EPS of $-2.07. -We do not have a set dividend date for Ginkgo Bioworks Holdings Inc at this time. Click Here To Get The Full Report on Ginkgo Bioworks Holdings Inc (DNA)

Share this article: